2018
DOI: 10.1155/2018/1823726
|View full text |Cite
|
Sign up to set email alerts
|

GPRC5A: An Emerging Biomarker in Human Cancer

Abstract: Aberrant expression of G protein-coupled receptors (GPCRs) is frequently associated with tumorigenesis. G Protein-coupled receptor class C group 5 member A (GPRC5A) is a member of the GPCR superfamily, is expressed preferentially in lung tissues, and is regulated by various entities at multiple levels. GPRC5A exerts a tumor suppressive role in lung cancer and GPRC5A deletion promotes lung tumor initiation and progression. Recent advances have highlighted that GPRC5A dysregulation is found in various human canc… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
32
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 33 publications
(36 citation statements)
references
References 96 publications
2
32
0
Order By: Relevance
“…Many observations have highlighted a strong connection between alterations in GPRC5A and several human cancers (Jiang et al, 2018), and in particular with the presence of more aggressive and metastatic phenotypes through the induction of the EMT Sawada et al, 2020;Liu et al, 2017). EMT takes place physiologically during embryonic development, tissue regeneration, organ fibrosis, and wound healing.…”
Section: Discussionmentioning
confidence: 99%
“…Many observations have highlighted a strong connection between alterations in GPRC5A and several human cancers (Jiang et al, 2018), and in particular with the presence of more aggressive and metastatic phenotypes through the induction of the EMT Sawada et al, 2020;Liu et al, 2017). EMT takes place physiologically during embryonic development, tissue regeneration, organ fibrosis, and wound healing.…”
Section: Discussionmentioning
confidence: 99%
“…GPCRomics may identify GPCRs amenable to such approaches and may help guide appropriate hiPSC-derived models for drug screening and perhaps, cell therapy. Newly recognized GPCRs may also be useful as biomarkers that can be analyzed on circulating (tumor, fetal) cells, exosomes in the blood or urine or as cell surface proteins detectable with antibodies or other probes, perhaps via imaging methods [32,[84][85][86][87][88][89]. Such techniques may further facilitate personalized/precision medicine approaches for GPCR therapeutics: identification of individual and groups of patients who express one or more GPCRs that can be treated with appropriate GPCR-targeted agents and whose response is monitored by biomarker analyses.…”
Section: Resultsmentioning
confidence: 99%
“…Another protein present in the media from five conceptuses (heavy labelled in CCM from three conceptuses) is GPRC5A. This protein belongs to a group of receptors and has been found to be dysregulated in cancer [51] and is a lung cancer suppressor gene [52]. In GPRC5A-knock out mice, prostaglandin E2 synthase (PTGES)/prostaglandin E2 (PGE2) signaling is highly associated with tumorigenesis and metastasis and is related to immune suppression in lung cancer [52].…”
Section: De Novo Synthesised Proteins In Conceptus-conditioned Mediamentioning
confidence: 99%